Sugi Predict

Sugi Predict / Compounds / SCHEMBL2279767

SCHEMBL2279767

SCHEMBL2279767

Cc1nnc2c3cc(-c4ccccc4)c(-c4ccc([C@@H](C)N)cc4)nc3ccn12

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ AKT1 P31749 11/20 0.47
▸ AKT2 P31751 11/20 0.47
▸ KCNH2 Q12809 3/20 0.47
▸ AKT3 Q9Y243 2/20 0.43
▸ FECH P22830 1/20 0.43
▸ HSD17B10 Q99714 2/20 0.39
▸ POLB P06746 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ TSHR P16473 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ HPGD P15428 1/20 0.35
▸ PSMB5 P28074 1/20 0.34
▸ DHODH Q02127 1/20 0.33
▸ PDE10A Q9Y233 1/20 0.33
▸ ADK P55263 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2285889 0.99 AKT1 (0.46) AKT1AKT2KCNH2AKT3FECH
SCHEMBL2283207 0.87 AKT1 (0.44) AKT1AKT2KCNH2AKT3FECH
SCHEMBL2284709 0.87 AKT1 (0.42) AKT1AKT2KCNH2AKT3FECH
SCHEMBL2283320 0.84 AKT1 (0.53) AKT1AKT2KCNH2AKT3FECH
SCHEMBL2280976 0.84 AKT1 (0.42) AKT1AKT2KCNH2AKT3FECH
SCHEMBL2279967 0.83 AKT1 (0.43) AKT1AKT2KCNH2AKT3FECH
SCHEMBL2281325 0.83 AKT1 (0.50) AKT1AKT2KCNH2AKT3FECH
Hydrochloric Acid SCHEMBL3504287 0.83 AKT1 (0.53) AKT1AKT2KCNH2AKT3FECH
SCHEMBL2279848 0.83 AKT1 (0.54) AKT1AKT2KCNH2AKT3FECH
Hydrochloric Acid SCHEMBL2276469 0.82 AKT1 (0.49) AKT1AKT2KCNH2AKT3FECH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1898903-B1 INHIBITORS OF AKT ACTIVITY MERCK SHARP & DOHME (US) 2013-03-27 — — EP claimed
US-8008317-B2 Inhibitors of akt activtiy MERCK SHARP & DOHME CORP. (US) 2011-08-30 — — US claimed
US-20100222321-A1 Inhibitors of akt activtiy MERCK SHARP & DOHME LLC 2010-09-02 — — US claimed
EP-1898903-B1 INHIBITORS OF AKT ACTIVITY MERCK SHARP & DOHME (US) 2013-03-27 — — EP disclosed
US-8008317-B2 Inhibitors of akt activtiy MERCK SHARP & DOHME CORP. (US) 2011-08-30 — — US disclosed
US-8008317-B2 Inhibitors of akt activtiy MERCK SHARP & DOHME CORP. (US) 2011-08-30 — — US disclosed
US-8008317-B2 Inhibitors of akt activtiy MERCK SHARP & DOHME CORP. (US) 2011-08-30 — — US disclosed
US-20100222321-A1 Inhibitors of akt activtiy MERCK SHARP & DOHME LLC 2010-09-02 — — US disclosed
US-20100222321-A1 Inhibitors of akt activtiy MERCK SHARP & DOHME LLC 2010-09-02 — — US disclosed
US-20100222321-A1 Inhibitors of akt activtiy MERCK SHARP & DOHME LLC 2010-09-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100222321-A1 Inhibitors of akt activtiy PIK3CA, PIK3CD, INPP5D AKT1 8/4885AKT2 4/4885KCNH2 3672/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.